328 related articles for article (PubMed ID: 19402856)
1. International collaborative study to evaluate candidate reference reagents to standardize haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulin products.
Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
Vox Sang; 2009 Aug; 97(2):160-8. PubMed ID: 19402856
[TBL] [Abstract][Full Text] [Related]
2. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method.
Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):39-50. PubMed ID: 20223189
[TBL] [Abstract][Full Text] [Related]
3. International collaborative study to evaluate a candidate reference preparation to define an appropriate specified limit of anti-D in intravenous immunoglobulin products.
Thorpe SJ; Fox B; Heath A; Dolman C; Virata ML; Yu MW; Thorpe R
Vox Sang; 2005 May; 88(4):278-87. PubMed ID: 15877651
[TBL] [Abstract][Full Text] [Related]
4. International collaborative study to assess candidate reference preparations to control the level of anti-D in IVIG for use in Europe and the United States.
Thorpe SJ; Fox B; Heath A; Behr-Gross ME; Virata ML; Yu MY
Biologicals; 2006 Sep; 34(3):209-12. PubMed ID: 16492398
[TBL] [Abstract][Full Text] [Related]
5. International standards for minimum potency of anti-A and anti-B blood grouping reagents: evaluation of candidate preparations in an international collaborative study.
Thorpe SJ; Fox B; Heath AB; Scott M; de Haas M; Kochman S; Padilla A
Vox Sang; 2006 Nov; 91(4):336-44. PubMed ID: 17105610
[TBL] [Abstract][Full Text] [Related]
6. Anti-A and anti-B activity in batches of different intravenous immunoglobulin products determined using a direct haemagglutination method.
Thorpe SJ; Fox BJ; Dolman CD; Thorpe R
Biologicals; 2005 Jun; 33(2):111-6. PubMed ID: 15905100
[TBL] [Abstract][Full Text] [Related]
7. A WHO reference reagent to standardize haemagglutination testing for anti-A and anti-B in serum and plasma: international collaborative study to evaluate a candidate preparation.
Thorpe SJ; Fox B; Sharp G; White J; Milkins C
Vox Sang; 2016 Aug; 111(2):161-70. PubMed ID: 27007982
[TBL] [Abstract][Full Text] [Related]
8. An International Standard for specifying the minimum potency of anti-D blood-grouping reagents: evaluation of a candidate preparation in an international collaborative study.
Thorpe SJ; Fox B; Heath AB; Scott M; de Haas M; Kochman S; Padilla A
Vox Sang; 2006 Feb; 90(2):131-9. PubMed ID: 16430672
[TBL] [Abstract][Full Text] [Related]
9. International collaborative study to establish immunoglobulin (anti-D test) BRP batch 1.
Thorpe SJ; Fox B; Heath A; Behr-Gross ME; Virata ML; Yu MW
Pharmeuropa Bio; 2006 Nov; 2006(1):49-56. PubMed ID: 17270131
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic kits in parasitology: which controls?].
Rossi P
Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
[TBL] [Abstract][Full Text] [Related]
11. International collaborative study to assess new stocks of candidate reference preparations to control the level of anti-D in IVIG.
Thorpe SJ; Virata ML; Fox B; Terao E
Pharmeur Bio Sci Notes; 2024; 2024():76-89. PubMed ID: 38949845
[TBL] [Abstract][Full Text] [Related]
12. Anti-Rh D activity of commercial intravenous immunoglobulin preparations.
Turner CE; Thorpe SJ; Brasher MD; Thorpe R
Vox Sang; 1999; 76(1):55-8. PubMed ID: 9933855
[TBL] [Abstract][Full Text] [Related]
13. International reference reagents to standardise blood group genotyping: evaluation of candidate preparations in an international collaborative study.
Boyle J; Thorpe SJ; Hawkins JR; Lockie C; Fox B; Matejtschuk P; Halls C; Metcalfe P; Rigsby P; Armstrong-Fisher S; Varzi AM; Urbaniak S; Daniels G
Vox Sang; 2013 Feb; 104(2):144-52. PubMed ID: 22882606
[TBL] [Abstract][Full Text] [Related]
14. Collaborative study for the establishment of the WHO 3(rd) International Standard for Endotoxin, the Ph. Eur. endotoxin biological reference preparation batch 5 and the USP Reference Standard for Endotoxin Lot H0K354.
Findlay L; Desai T; Heath A; Poole S; Crivellone M; Hauck W; Ambrose M; Morris T; Daas A; Rautmann G; Buchheit KH; Spieser JM; Terao E
Pharmeur Bio Sci Notes; 2015; 2015():73-98. PubMed ID: 26830160
[TBL] [Abstract][Full Text] [Related]
15. Specifications for anti-A and anti-B in intravenous immunoglobulin: history and rationale.
Thorpe SJ
Transfusion; 2015 Jul; 55 Suppl 2():S80-5. PubMed ID: 26174902
[TBL] [Abstract][Full Text] [Related]
16. Anti-red blood cell antibodies, free light chains, and antiphospholipid antibodies in intravenous immunoglobulin preparations.
Sakem B; Matozan K; Nydegger UE; Weigel G; Griesmacher A; Risch L
Isr Med Assoc J; 2013 Oct; 15(10):617-21. PubMed ID: 24266088
[TBL] [Abstract][Full Text] [Related]
17. Reducing the variation in performance of antibody titrations.
AuBuchon JP; de Wildt-Eggen J; Dumont LJ; ;
Vox Sang; 2008 Jul; 95(1):57-65. PubMed ID: 18479347
[TBL] [Abstract][Full Text] [Related]
18. Anti-A and anti-B haemagglutinin levels in intravenous immunoglobulins: are they on the rise? A comparison of four different analysis methods and six products.
Bellac CL; Polatti D; Hottiger T; Girard P; Sänger M; Gilgen M
Biologicals; 2014 Jan; 42(1):57-64. PubMed ID: 24325871
[TBL] [Abstract][Full Text] [Related]
19. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
Buchheit KH; Daas A; Stalder J
Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
[TBL] [Abstract][Full Text] [Related]
20. Batches of intravenous immunoglobulin associated with adverse reactions in recipients contain atypically high anti-Rh D activity.
Thorpe SJ; Fox BJ; Dolman CD; Lawrence J; Thorpe R
Vox Sang; 2003 Aug; 85(2):80-4. PubMed ID: 12925158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
